52,017.55
(829.55)
(1.62%)
17 Sep , 2026 | 04:14 PM
Open
51,191.1
Prev. Close
51,188
Market Cap.
₹0
Div Yield
0.3
PE
44.69
PB
44.69
51,112.15
52,067.35
Performance
One Week (%)
-2.62
One Month (%)
-1.59
One Year (%)
13.88
YTD (%)
21.8
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 25,910 | 26,280 | 25,830 | 5,141 |
Glaxosmithkline Pharmaceuticals Ltd | 2,799.9 | 2,862.3 | 2,794.5 | 28,739 |
Pfizer Ltd | 4,014.8 | 4,040 | 3,985.5 | 20,865 |
Lupin Ltd | 2,098.1 | 2,098.1 | 2,046.3 | 5,25,909 |
Ipca Laboratories Ltd | 1,970.3 | 2,014 | 1,937.9 | 5,55,590 |
Neuland Laboratories Ltd | 22,665 | 22,980 | 22,525 | 18,964 |
Aurobindo Pharma Ltd | 1,690 | 1,692.3 | 1,634 | 7,58,827 |
Natco Pharma Ltd | 818.25 | 820 | 805.75 | 3,40,518 |
Wockhardt Ltd | 2,072.3 | 2,090.1 | 2,021.5 | 6,03,193 |
Granules India Ltd | 870.4 | 874 | 838.2 | 9,15,976 |
Ajanta Pharma Ltd | 3,500.5 | 3,530.1 | 3,481 | 97,948 |
Poly Medicure Ltd | 1,712.7 | 1,753 | 1,700.1 | 93,343 |
Gland Pharma Ltd | 2,907.8 | 2,941.1 | 2,820.1 | 6,78,985 |
Biocon Ltd | 380 | 382 | 370.5 | 30,43,285 |
Alkem Laboratories Ltd | 5,348.5 | 5,361 | 5,161.5 | 2,31,871 |
Glenmark Pharmaceuticals Ltd | 2,416 | 2,416.9 | 2,388.4 | 2,27,416 |
Fortis Healthcare Ltd | 886.1 | 897 | 874.35 | 11,75,220 |
Syngene International Ltd | 380.2 | 381.5 | 376.1 | 1,60,993 |
Global Health Ltd | 1,424 | 1,438.3 | 1,404.2 | 1,52,324 |
Krishna Institute of Medical Sciences Ltd | 791.85 | 799.05 | 763.05 | 10,82,406 |
Mankind Pharma Ltd | 2,300 | 2,308.8 | 2,242.1 | 4,88,064 |
Dr Lal Pathlabs Ltd | 1,924.7 | 1,941.1 | 1,888 | 3,54,166 |
Narayana Hrudayalaya Ltd | 1,868.6 | 1,884.4 | 1,848.3 | 1,27,928 |
Laurus Labs Ltd | 1,948.1 | 1,964.5 | 1,894.8 | 16,45,108 |
Sai Life Sciences Ltd | 1,545.7 | 1,569.6 | 1,530.2 | 4,43,745 |
Aster DM Quality Care Ltd | 760.65 | 764.4 | 738.05 | 6,34,636 |
Acutaas Chemicals Ltd | 3,315.1 | 3,366 | 3,282 | 1,82,520 |
Cohance Lifesciences Ltd | 439.95 | 446.5 | 428.05 | 11,64,491 |
Piramal Pharma Ltd | 204.71 | 206.78 | 201.91 | 24,75,167 |
OneSource Specialty Pharma Ltd | 1,580 | 1,621.8 | 1,569.6 | 1,21,361 |
The NSE IPO opens on September 17 with a price band of ₹1,700–₹1,785 per share. NSE CEO Ashish Chauhan said demand has been unexpectedly large, while the GMP has cooled to ₹145 from ₹218 on September 11.
16 Sep 2026|11:13 AM
Indian stock markets opened higher on September 16 after the Nifty 50 closed at a five-month low. Sensex and Nifty are attempting a technical rebound, while crude oil, US Treasury yields, the Fed decision and IPO activity remain key market triggers.
16 Sep 2026|10:26 AM
Indian stock markets came under pressure on September 11 as the Sensex fell over 400 points and the Nifty slipped below 23,300. Realty and metal stocks led the decline, while rising bond yields, crude oil prices and Fed rate-hike expectations weighed on investor sentiment.
11 Sep 2026|11:19 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
